Cargando…
Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model
BACKGROUND: The therapeutic potential of mesenchymal stem cells (MSCs)-derived conditioned media (CM) can be increased after preconditioning with various chemical agents. The aim of this study is comparative evaluation of effects of N-CM and DFS-CM which are collected from normal (N) and deferoxamin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438289/ https://www.ncbi.nlm.nih.gov/pubmed/36056427 http://dx.doi.org/10.1186/s13287-022-03121-6 |
_version_ | 1784781795937484800 |
---|---|
author | Ozkan, Serbay Isildar, Basak Ercin, Merve Gezginci-Oktayoglu, Selda Konukoglu, Dildar Neşetoğlu, Neşet Oncul, Mahmut Koyuturk, Meral |
author_facet | Ozkan, Serbay Isildar, Basak Ercin, Merve Gezginci-Oktayoglu, Selda Konukoglu, Dildar Neşetoğlu, Neşet Oncul, Mahmut Koyuturk, Meral |
author_sort | Ozkan, Serbay |
collection | PubMed |
description | BACKGROUND: The therapeutic potential of mesenchymal stem cells (MSCs)-derived conditioned media (CM) can be increased after preconditioning with various chemical agents. The aim of this study is comparative evaluation of effects of N-CM and DFS-CM which are collected from normal (N) and deferoxamine (DFS) preconditioned umbilical cord-derived MSCs on rat diabetic nephropathy (DN) model. METHODS: After incubation of the MSCs in serum-free medium with/without 150 µM DFS for 48 h, the contents of N-CM and DFS-CM were analyzed by enzyme-linked immunosorbent assay. Diabetes (D) was induced by single dose of 55 mg/kg streptozotocin. Therapeutic effects of CMs were evaluated by biochemical, physical, histopathological and immunohistochemical analysis. RESULTS: The concentrations of vascular endothelial growth factor alpha, nerve growth factor and glial-derived neurotrophic factor in DFS-CM increased, while one of brain-derived neurotrophic factor decreased in comparison with N-CM. The creatinine clearance rate increased significantly in both treatment groups, while the improvement in albumin/creatinine ratio and renal mass index values were only significant for D + DFS-CM group. Light and electron microscopic deteriorations and loss of podocytes-specific nephrin and Wilms tumor-1 (WT-1) expressions were significantly restored in both treatment groups. Tubular beclin-1 expression was significantly increased for DN group, but it decreased in both treatment groups. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive apoptotic cell death increased in the tubules of D group, while it was only significantly decreased for D + DFS-CM group. CONCLUSIONS: DFS-CM can be more effective in the treatment of DN by reducing podocyte damage and tubular apoptotic cell death and regulating autophagic activity with its more concentrated secretome content than N-CM. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03121-6. |
format | Online Article Text |
id | pubmed-9438289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94382892022-09-03 Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model Ozkan, Serbay Isildar, Basak Ercin, Merve Gezginci-Oktayoglu, Selda Konukoglu, Dildar Neşetoğlu, Neşet Oncul, Mahmut Koyuturk, Meral Stem Cell Res Ther Research BACKGROUND: The therapeutic potential of mesenchymal stem cells (MSCs)-derived conditioned media (CM) can be increased after preconditioning with various chemical agents. The aim of this study is comparative evaluation of effects of N-CM and DFS-CM which are collected from normal (N) and deferoxamine (DFS) preconditioned umbilical cord-derived MSCs on rat diabetic nephropathy (DN) model. METHODS: After incubation of the MSCs in serum-free medium with/without 150 µM DFS for 48 h, the contents of N-CM and DFS-CM were analyzed by enzyme-linked immunosorbent assay. Diabetes (D) was induced by single dose of 55 mg/kg streptozotocin. Therapeutic effects of CMs were evaluated by biochemical, physical, histopathological and immunohistochemical analysis. RESULTS: The concentrations of vascular endothelial growth factor alpha, nerve growth factor and glial-derived neurotrophic factor in DFS-CM increased, while one of brain-derived neurotrophic factor decreased in comparison with N-CM. The creatinine clearance rate increased significantly in both treatment groups, while the improvement in albumin/creatinine ratio and renal mass index values were only significant for D + DFS-CM group. Light and electron microscopic deteriorations and loss of podocytes-specific nephrin and Wilms tumor-1 (WT-1) expressions were significantly restored in both treatment groups. Tubular beclin-1 expression was significantly increased for DN group, but it decreased in both treatment groups. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive apoptotic cell death increased in the tubules of D group, while it was only significantly decreased for D + DFS-CM group. CONCLUSIONS: DFS-CM can be more effective in the treatment of DN by reducing podocyte damage and tubular apoptotic cell death and regulating autophagic activity with its more concentrated secretome content than N-CM. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03121-6. BioMed Central 2022-09-02 /pmc/articles/PMC9438289/ /pubmed/36056427 http://dx.doi.org/10.1186/s13287-022-03121-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ozkan, Serbay Isildar, Basak Ercin, Merve Gezginci-Oktayoglu, Selda Konukoglu, Dildar Neşetoğlu, Neşet Oncul, Mahmut Koyuturk, Meral Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model |
title | Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model |
title_full | Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model |
title_fullStr | Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model |
title_full_unstemmed | Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model |
title_short | Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model |
title_sort | therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438289/ https://www.ncbi.nlm.nih.gov/pubmed/36056427 http://dx.doi.org/10.1186/s13287-022-03121-6 |
work_keys_str_mv | AT ozkanserbay therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel AT isildarbasak therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel AT ercinmerve therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel AT gezgincioktayogluselda therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel AT konukogludildar therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel AT nesetogluneset therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel AT onculmahmut therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel AT koyuturkmeral therapeuticpotentialofconditionedmediumobtainedfromdeferoxaminepreconditionedumbilicalcordmesenchymalstemcellsondiabeticnephropathymodel |